Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Technique Helps Surgeons Identify Bacteria

By LabMedica International staff writers
Posted on 09 Nov 2011
A faster, less expensive method has been developed for identifying bacterial infections and determining their antibiotic resistance.

The technology known as Raman spectroscopy looks at the bacteria's infrared wavelengths and pinpoint unique patterns of molecular vibration in blood samples.

Surgeons at the Detroit Medical Center at Wayne State University (Detroit, MI, USA) observed 120 spectral patterns from four strains of antibiotic resistant Staphylococcus aureus: two that were sensitive to the antibiotic methicillin, one that was resistant to methicillin and a more stubborn form of Staphylococcus infection that has a reduced susceptibility to a last-resort antibiotic called vancomycin (RVS-MRSA).

Raman spectroscopy enabled the scientists to distinguish the methicillin, sensitive S. More...
aureus (MSSA) from methicillin resistant S. aureus (MRSA) with 90.2% accuracy. They also could tell the difference between MRSA and its more stubborn form, RVS-MRSA, with 96.3% accuracy. The S. aureus profiles were then entered into a statistical program to create a preformed model of the Raman spectra. When the surgeons tested new spectra, the program was 98% accurate in classifying the bacteria as one of the four strains.

The S. aureus profiles generated by Raman spectroscopy are among dozens of pathogen profiles being added to a database of other bacteria, viruses, malignant tumors, and fungi. The team is simultaneously developing a technology to integrate the pathogen database and the Raman spectroscopy technique into a hand-held device that would cut turnaround times for diagnostic test results from several hours to about 10 minutes.

Amy Riley Spencer, MD, who led the study said, "Currently, emergency room patients may have to wait about six hours before diagnostic tests can identify a Staphylococcus infection and another 24 to 72 hours to determine which antibiotics could treat it. Our findings suggest that Raman spectroscopy can identify the infection earlier and save money by treating the infection quicker instead of hoping an antibiotic is working and then switching when it does not."

The findings were reported on October 26, 2011 at the 2011 Annual Clinical Congress of the American College of Surgeons, held in San Francisco (CA, USA).

Related Links:

Detroit Medical Center


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.